Adaptation-proof SARS-CoV-2 vaccine design is one step close

A vaccine design approach that could protect against new variants of SARS-CoV-2, the virus that causes COVID-19, but also potentially protects against other coronaviruses is one step closer to reality as a result of Penn State College of Medicine research.

Related Keywords

G Thomas Passananti , Yashavantha Vishweshwaraiah , Nikolay Dokholyan , Emily Henderson , Centers For Disease , Penn State College Of Medicine , Department Of Pharmacology , Penn State College , Passananti Professor , Vice Chair , Disease Control , Genomics Industry Focus , Advanced Functional Materials , Covid 19 , Vaccine , Ngiotensin , Ngiotensin Converting Enzyme 2 , Antibodies , Ntibody , Nzyme , Immune Response , Medicine , Utation , Harmacology , Protein , Eceptor , Research , Cars , Ars Cov 2 , Spike Protein , Students , Virus ,